NYSE:BAX - Baxter International Stock Price, News, Headlines & Rumors

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, July 17th. Investors of record on Friday, August 31st will be given a dividend of $0.19 per share on Monday, October 1st. This represents a $0.76 dividend on an annualized basis and a yield of 1.06%. The ex-dividend date of this dividend is Thursday, August 30th. View Baxter International's Dividend History.

Baxter International announced that its Board of Directors has authorized a share repurchase plan on Wednesday, February 21st 2018, which authorizes the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company's board of directors believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) posted its quarterly earnings results on Thursday, July, 26th. The medical instruments supplier reported $0.77 EPS for the quarter, beating the Zacks' consensus estimate of $0.71 by $0.06. The medical instruments supplier earned $2.84 billion during the quarter, compared to analysts' expectations of $2.83 billion. Baxter International had a return on equity of 16.63% and a net margin of 8.29%. Baxter International's revenue for the quarter was up 9.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.63 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Wednesday, October, 24th 2018. View Earnings Estimates for Baxter International.

Baxter International updated its FY18 earnings guidance on Thursday, July, 26th. The company provided EPS guidance of $2.94-3.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.89. Baxter International also updated its Q3 guidance to $0.72-0.74 EPS.

13 equities research analysts have issued 1 year price targets for Baxter International's stock. Their forecasts range from $62.00 to $85.00. On average, they expect Baxter International's stock price to reach $75.6154 in the next twelve months. This suggests a possible upside of 5.4% from the stock's current price. View Analyst Price Targets for Baxter International.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), ICU Medical (ICUI), Integra Lifesciences (IART), Haemonetics (HAE), Globus Medical (GMED) and Insulet (PODD).

Headlines about BAX stock have been trending somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Baxter International earned a media and rumor sentiment score of 0.18 on Accern's scale. They also assigned headlines about the medical instruments supplier an impact score of 46.32 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for Baxter International.

Baxter International's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.82%), FMR LLC (5.36%), Veritas Asset Management LLP (1.65%), Wells Fargo & Company MN (1.07%), Bank of New York Mellon Corp (0.82%) and Janus Henderson Group PLC (0.75%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Partner Fund Management L.P., Canada Pension Plan Investment Board, Renaissance Technologies LLC, Veritas Asset Management LLP, Great West Life Assurance Co. Can, Starboard Value LP and Schwab Charles Investment Management Inc.. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Voya Investment Management LLC, Morgan Stanley, Standard Life Aberdeen plc, SPF Beheer BV, Marshall Wace LLP, Obermeyer Wood Investment Counsel Lllp and Putnam Investments LLC. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $71.73.

Baxter International has a market capitalization of $38.20 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]